Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.45 |
| ▸ | GNPAT | O15228 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 5/20 | 0.40 |
| ▸ | FNTB | P49356 | 5/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630632 | 0.93 | LMNA (0.46) | MMELMNAFNTAFNTBPGGT1B | |
| SCHEMBL4284629 | 0.90 | LMNA (0.48) | MMELMNAFNTAFNTBPGGT1B | |
| SCHEMBL4284627 | 0.90 | LMNA (0.48) | MMELMNAFNTAFNTBPGGT1B | |
| SCHEMBL31438607 | 0.90 | PDCD1LG2 (0.42) | MMELMNAFNTAFNTBPGGT1B | |
| SCHEMBL30575172 | 0.89 | LMNA (0.48) | LMNAFNTAFNTBPGGT1B | |
| SCHEMBL15010984 | 0.89 | LMNA (0.47) | GNPATLMNAFNTAFNTBPGGT1B | |
| SCHEMBL6969766 | 0.89 | LMNA (0.47) | GNPATLMNAFNTAFNTBPGGT1B | |
| SCHEMBL29591191 | 0.89 | GNPAT (0.40) | GNPATLMNAFNTAFNTBPGGT1B | |
| SCHEMBL29537033 | 0.88 | GNPAT (0.48) | GNPATLMNAFNTAFNTBPGGT1B | |
| SCHEMBL29678007 | 0.88 | GNPAT (0.48) | GNPATLMNAFNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |